Related references
Note: Only part of the references are listed.Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors
Olga N. Hernandez de la Cruz et al.
FRONTIERS IN ONCOLOGY (2020)
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
Dayana Herrera-Rios et al.
FRONTIERS IN IMMUNOLOGY (2020)
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Grant M. Fischer et al.
CANCER DISCOVERY (2019)
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases
Maria J. Sambade et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy
Thuy T. Tran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Immune Landscape of Cancer (vol 48, pg 812, 2018)
Vesteinn Thorsson et al.
IMMUNITY (2019)
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
Harriet M. Kluger et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
γδ T cells in cancer: a small population of lymphocytes with big implications
Mathilde Raverdeau et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long et al.
LANCET ONCOLOGY (2018)
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models
Brad A. Friedman et al.
CELL REPORTS (2018)
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Michael A. Davies et al.
LANCET ONCOLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
γδ T Cells: Unexpected Regulators of Cancer Development and Progression
Christopher Fleming et al.
TRENDS IN CANCER (2017)
Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms
Roger Murayi et al.
CHILDS NERVOUS SYSTEM (2016)
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
Jessica Donato et al.
BLOOD (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2015)
Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC
Xiaobei Zhao et al.
PLOS ONE (2015)
Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
Guo Chen et al.
CLINICAL CANCER RESEARCH (2014)
Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
Gina Song et al.
CLINICAL CANCER RESEARCH (2014)
Development of DNA Damage Response Signaling Biomarkers using Automated, Quantitative Image Analysis
Nana Nikolaishvilli-Feinberg et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Vascular channels formed by subpopulations of PECAM1+ melanoma cells
James M. Dunleavey et al.
NATURE COMMUNICATIONS (2014)
Pathologic and gene expression features of metastatic melanomas to the brain
Ronald Hamilton et al.
CANCER (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Sara C. Hanna et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation
I. Garcia et al.
ONCOGENE (2013)
Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties?
Claire Lugassy et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Moritz Felcht et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
Christopher Lieu et al.
CLINICAL CANCER RESEARCH (2011)
Pericytes and vessel maturation during tumor angiogenesis and metastasis
Ahmad Raza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Analysis of data with multiple sources of correlation in the framework of generalized estimating equations
J Shults et al.
STATISTICS IN MEDICINE (2004)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
